Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Jette

Showing results (41-50 of 54) with videos related to

Pageof 6
Sort By:
Cell|May 31, 2008
Chk1 suppresses a caspase-2 apoptotic response to DNA damage that bypasses p53, Bcl-2, and caspase-3Samuel Sidi, Takaomi Sanda, Richard D Kennedy, et al.
Biorxiv : the Preprint Server for Biology|May 5, 2021
Broad cross-reactivity across sarbecoviruses exhibited by a subset of COVID-19 donor-derived neutralizing antibodiesClaudia A Jette, Alexander A Cohen, Priyanthi N P Gnanapragasam, et al.
Frontiers in Immunology|April 7, 2025
Multi-targeted, NOT gated CAR-T cells as a strategy to protect normal lineages for blood cancer therapyBreanna DiAndreth, Pavlo A Nesterenko, Aaron G Winters, et al.
Cell Reports|December 22, 2021
Broad cross-reactivity across sarbecoviruses exhibited by a subset of COVID-19 donor-derived neutralizing antibodiesClaudia A Jette, Alexander A Cohen, Priyanthi N P Gnanapragasam, et al.
Cell Reports|September 17, 2021
Broad cross-reactivity across sarbecoviruses exhibited by a subset of COVID-19 donor-derived neutralizing antibodiesClaudia A Jette, Alexander A Cohen, Priyanthi N P Gnanapragasam, et al.
Cancer Cell|June 11, 2024
T-Lymphoblastic Lymphoma Cells Express High Levels of BCL2, S1P1, and ICAM1, Leading to a Blockade of Tumor Cell IntravasationHui Feng, David L Stachura, Richard M White, et al.
Cancer Cell|October 19, 2010
T-lymphoblastic lymphoma cells express high levels of BCL2, S1P1, and ICAM1, leading to a blockade of tumor cell intravasationHui Feng, David L Stachura, Richard M White, et al.
Nature|October 12, 2020
SARS-CoV-2 neutralizing antibody structures inform therapeutic strategiesChristopher O Barnes, Claudia A Jette, Morgan E Abernathy, et al.
Nature|April 2, 2024
Author Correction: SARS-CoV-2 neutralizing antibody structures inform therapeutic strategiesChristopher O Barnes, Claudia A Jette, Morgan E Abernathy, et al.
Biorxiv : the Preprint Server for Biology|September 2, 2020
Structural classification of neutralizing antibodies against the SARS-CoV-2 spike receptor-binding domain suggests vaccine and therapeutic strategiesChristopher O Barnes, Claudia A Jette, Morgan E Abernathy, et al.
Pageof 6

Showing results (41-50 of 54) with videos related to

Sort By:
Pageof 6
Cell|May 31, 2008
Chk1 suppresses a caspase-2 apoptotic response to DNA damage that bypasses p53, Bcl-2, and caspase-3Samuel Sidi, Takaomi Sanda, Richard D Kennedy, et al.
Biorxiv : the Preprint Server for Biology|May 5, 2021
Broad cross-reactivity across sarbecoviruses exhibited by a subset of COVID-19 donor-derived neutralizing antibodiesClaudia A Jette, Alexander A Cohen, Priyanthi N P Gnanapragasam, et al.
Frontiers in Immunology|April 7, 2025
Multi-targeted, NOT gated CAR-T cells as a strategy to protect normal lineages for blood cancer therapyBreanna DiAndreth, Pavlo A Nesterenko, Aaron G Winters, et al.
Cell Reports|December 22, 2021
Broad cross-reactivity across sarbecoviruses exhibited by a subset of COVID-19 donor-derived neutralizing antibodiesClaudia A Jette, Alexander A Cohen, Priyanthi N P Gnanapragasam, et al.
Cell Reports|September 17, 2021
Broad cross-reactivity across sarbecoviruses exhibited by a subset of COVID-19 donor-derived neutralizing antibodiesClaudia A Jette, Alexander A Cohen, Priyanthi N P Gnanapragasam, et al.
Cancer Cell|June 11, 2024
T-Lymphoblastic Lymphoma Cells Express High Levels of BCL2, S1P1, and ICAM1, Leading to a Blockade of Tumor Cell IntravasationHui Feng, David L Stachura, Richard M White, et al.
Cancer Cell|October 19, 2010
T-lymphoblastic lymphoma cells express high levels of BCL2, S1P1, and ICAM1, leading to a blockade of tumor cell intravasationHui Feng, David L Stachura, Richard M White, et al.
Nature|October 12, 2020
SARS-CoV-2 neutralizing antibody structures inform therapeutic strategiesChristopher O Barnes, Claudia A Jette, Morgan E Abernathy, et al.
Nature|April 2, 2024
Author Correction: SARS-CoV-2 neutralizing antibody structures inform therapeutic strategiesChristopher O Barnes, Claudia A Jette, Morgan E Abernathy, et al.
Biorxiv : the Preprint Server for Biology|September 2, 2020
Structural classification of neutralizing antibodies against the SARS-CoV-2 spike receptor-binding domain suggests vaccine and therapeutic strategiesChristopher O Barnes, Claudia A Jette, Morgan E Abernathy, et al.
Pageof 6